Company page

Veracyte, Inc.

Veracyte, Inc. (Ticker: VCYT) is a public company based in America, specializing in genomic diagnostics. With a market capitalization of approximately $4.28 billion, Veracyte focuses on providing innovative solutions for patients and healthcare providers in the field of cancer and other diseases. The company's commitment to advancing precision medicine is reflected in its range of diagnostic tests and services.